nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilutamide—CYP2C19—Methazolamide—glaucoma	0.106	0.218	CbGbCtD
Nilutamide—CYP2C9—Diclofenamide—glaucoma	0.102	0.211	CbGbCtD
Nilutamide—CYP2C9—Dorzolamide—glaucoma	0.0985	0.204	CbGbCtD
Nilutamide—CYP2C19—Timolol—glaucoma	0.0898	0.186	CbGbCtD
Nilutamide—CYP2C9—Methazolamide—glaucoma	0.0878	0.182	CbGbCtD
Nilutamide—Flutamide—CYP1B1—glaucoma	0.00795	1	CrCbGaD
Nilutamide—Rash—Methazolamide—glaucoma	0.000703	0.0014	CcSEcCtD
Nilutamide—Dermatitis—Methazolamide—glaucoma	0.000702	0.0014	CcSEcCtD
Nilutamide—Nausea—Carbachol—glaucoma	0.000702	0.0014	CcSEcCtD
Nilutamide—Sweating—Betaxolol—glaucoma	0.000698	0.00139	CcSEcCtD
Nilutamide—Headache—Methazolamide—glaucoma	0.000698	0.00139	CcSEcCtD
Nilutamide—Chest pain—Pilocarpine—glaucoma	0.000697	0.00139	CcSEcCtD
Nilutamide—Shock—Dorzolamide—glaucoma	0.000696	0.00138	CcSEcCtD
Nilutamide—Paraesthesia—Acetazolamide—glaucoma	0.000693	0.00138	CcSEcCtD
Nilutamide—Nausea—Levobunolol—glaucoma	0.000691	0.00137	CcSEcCtD
Nilutamide—Discomfort—Pilocarpine—glaucoma	0.000689	0.00137	CcSEcCtD
Nilutamide—Hyperhidrosis—Dorzolamide—glaucoma	0.000684	0.00136	CcSEcCtD
Nilutamide—Abdominal pain—Apraclonidine—glaucoma	0.000682	0.00136	CcSEcCtD
Nilutamide—Rash—Latanoprost—glaucoma	0.00068	0.00135	CcSEcCtD
Nilutamide—Dermatitis—Latanoprost—glaucoma	0.00068	0.00135	CcSEcCtD
Nilutamide—Dyspepsia—Acetazolamide—glaucoma	0.000679	0.00135	CcSEcCtD
Nilutamide—Headache—Latanoprost—glaucoma	0.000676	0.00134	CcSEcCtD
Nilutamide—Anorexia—Dorzolamide—glaucoma	0.000674	0.00134	CcSEcCtD
Nilutamide—Decreased appetite—Acetazolamide—glaucoma	0.000671	0.00133	CcSEcCtD
Nilutamide—Insomnia—Brimonidine—glaucoma	0.00067	0.00133	CcSEcCtD
Nilutamide—Oedema—Pilocarpine—glaucoma	0.000668	0.00133	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000666	0.00132	CcSEcCtD
Nilutamide—Paraesthesia—Brimonidine—glaucoma	0.000665	0.00132	CcSEcCtD
Nilutamide—Alopecia—Clonidine—glaucoma	0.000664	0.00132	CcSEcCtD
Nilutamide—Nausea—Methazolamide—glaucoma	0.000662	0.00132	CcSEcCtD
Nilutamide—Dyspnoea—Brimonidine—glaucoma	0.00066	0.00131	CcSEcCtD
Nilutamide—Shock—Pilocarpine—glaucoma	0.000657	0.00131	CcSEcCtD
Nilutamide—Rhinitis—Betaxolol—glaucoma	0.000656	0.0013	CcSEcCtD
Nilutamide—Dyspepsia—Brimonidine—glaucoma	0.000652	0.0013	CcSEcCtD
Nilutamide—Hypoaesthesia—Betaxolol—glaucoma	0.000651	0.00129	CcSEcCtD
Nilutamide—Angina pectoris—Timolol—glaucoma	0.00065	0.00129	CcSEcCtD
Nilutamide—Hyperhidrosis—Pilocarpine—glaucoma	0.000646	0.00128	CcSEcCtD
Nilutamide—Tension—Clonidine—glaucoma	0.000642	0.00128	CcSEcCtD
Nilutamide—Insomnia—Dorzolamide—glaucoma	0.00064	0.00127	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Brimonidine—glaucoma	0.000639	0.00127	CcSEcCtD
Nilutamide—Anorexia—Pilocarpine—glaucoma	0.000637	0.00127	CcSEcCtD
Nilutamide—Feeling abnormal—Acetazolamide—glaucoma	0.000636	0.00126	CcSEcCtD
Nilutamide—Nervousness—Clonidine—glaucoma	0.000635	0.00126	CcSEcCtD
Nilutamide—Paraesthesia—Dorzolamide—glaucoma	0.000635	0.00126	CcSEcCtD
Nilutamide—Pain—Brimonidine—glaucoma	0.000633	0.00126	CcSEcCtD
Nilutamide—Dyspnoea—Dorzolamide—glaucoma	0.000631	0.00125	CcSEcCtD
Nilutamide—Visual impairment—Betaxolol—glaucoma	0.00063	0.00125	CcSEcCtD
Nilutamide—Insomnia—Brinzolamide—glaucoma	0.000629	0.00125	CcSEcCtD
Nilutamide—Dyspnoea—Travoprost—glaucoma	0.000628	0.00125	CcSEcCtD
Nilutamide—Paraesthesia—Brinzolamide—glaucoma	0.000624	0.00124	CcSEcCtD
Nilutamide—Dyspepsia—Dorzolamide—glaucoma	0.000623	0.00124	CcSEcCtD
Nilutamide—Upper respiratory tract infection—Timolol—glaucoma	0.00062	0.00123	CcSEcCtD
Nilutamide—Dyspnoea—Brinzolamide—glaucoma	0.00062	0.00123	CcSEcCtD
Nilutamide—Dyspepsia—Travoprost—glaucoma	0.00062	0.00123	CcSEcCtD
Nilutamide—Asthenia—Apraclonidine—glaucoma	0.000619	0.00123	CcSEcCtD
Nilutamide—Decreased appetite—Dorzolamide—glaucoma	0.000615	0.00122	CcSEcCtD
Nilutamide—Erectile dysfunction—Timolol—glaucoma	0.000615	0.00122	CcSEcCtD
Nilutamide—Dyspepsia—Brinzolamide—glaucoma	0.000612	0.00122	CcSEcCtD
Nilutamide—Pruritus—Apraclonidine—glaucoma	0.00061	0.00121	CcSEcCtD
Nilutamide—Body temperature increased—Acetazolamide—glaucoma	0.00061	0.00121	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Travoprost—glaucoma	0.000608	0.00121	CcSEcCtD
Nilutamide—Ill-defined disorder—Clonidine—glaucoma	0.000607	0.00121	CcSEcCtD
Nilutamide—Pain—Dorzolamide—glaucoma	0.000605	0.0012	CcSEcCtD
Nilutamide—Insomnia—Pilocarpine—glaucoma	0.000604	0.0012	CcSEcCtD
Nilutamide—Decreased appetite—Brinzolamide—glaucoma	0.000604	0.0012	CcSEcCtD
Nilutamide—Weight decreased—Timolol—glaucoma	0.000604	0.0012	CcSEcCtD
Nilutamide—Pain—Travoprost—glaucoma	0.000602	0.0012	CcSEcCtD
Nilutamide—Constipation—Travoprost—glaucoma	0.000602	0.0012	CcSEcCtD
Nilutamide—Hyperglycaemia—Timolol—glaucoma	0.000602	0.0012	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Brinzolamide—glaucoma	0.0006	0.00119	CcSEcCtD
Nilutamide—Paraesthesia—Pilocarpine—glaucoma	0.0006	0.00119	CcSEcCtD
Nilutamide—Asthenia—Bimatoprost—glaucoma	0.0006	0.00119	CcSEcCtD
Nilutamide—Dyspnoea—Pilocarpine—glaucoma	0.000596	0.00118	CcSEcCtD
Nilutamide—Pain—Brinzolamide—glaucoma	0.000595	0.00118	CcSEcCtD
Nilutamide—Depression—Timolol—glaucoma	0.000593	0.00118	CcSEcCtD
Nilutamide—Pruritus—Bimatoprost—glaucoma	0.000592	0.00118	CcSEcCtD
Nilutamide—Diarrhoea—Apraclonidine—glaucoma	0.00059	0.00117	CcSEcCtD
Nilutamide—Malaise—Clonidine—glaucoma	0.00059	0.00117	CcSEcCtD
Nilutamide—Dyspepsia—Pilocarpine—glaucoma	0.000588	0.00117	CcSEcCtD
Nilutamide—Syncope—Clonidine—glaucoma	0.000586	0.00117	CcSEcCtD
Nilutamide—Feeling abnormal—Dorzolamide—glaucoma	0.000583	0.00116	CcSEcCtD
Nilutamide—Decreased appetite—Pilocarpine—glaucoma	0.000581	0.00115	CcSEcCtD
Nilutamide—Feeling abnormal—Travoprost—glaucoma	0.00058	0.00115	CcSEcCtD
Nilutamide—Gastrointestinal pain—Dorzolamide—glaucoma	0.000578	0.00115	CcSEcCtD
Nilutamide—Alopecia—Betaxolol—glaucoma	0.000578	0.00115	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000577	0.00115	CcSEcCtD
Nilutamide—Gastrointestinal pain—Travoprost—glaucoma	0.000576	0.00114	CcSEcCtD
Nilutamide—Loss of consciousness—Clonidine—glaucoma	0.000575	0.00114	CcSEcCtD
Nilutamide—Feeling abnormal—Brinzolamide—glaucoma	0.000573	0.00114	CcSEcCtD
Nilutamide—Pain—Pilocarpine—glaucoma	0.000571	0.00114	CcSEcCtD
Nilutamide—Constipation—Pilocarpine—glaucoma	0.000571	0.00114	CcSEcCtD
Nilutamide—Cough—Clonidine—glaucoma	0.000571	0.00113	CcSEcCtD
Nilutamide—Sweating—Timolol—glaucoma	0.000571	0.00113	CcSEcCtD
Nilutamide—Dizziness—Apraclonidine—glaucoma	0.00057	0.00113	CcSEcCtD
Nilutamide—Abdominal pain—Dorzolamide—glaucoma	0.000559	0.00111	CcSEcCtD
Nilutamide—Body temperature increased—Dorzolamide—glaucoma	0.000559	0.00111	CcSEcCtD
Nilutamide—Tension—Betaxolol—glaucoma	0.000559	0.00111	CcSEcCtD
Nilutamide—Chest pain—Clonidine—glaucoma	0.000557	0.00111	CcSEcCtD
Nilutamide—Abdominal pain—Travoprost—glaucoma	0.000557	0.00111	CcSEcCtD
Nilutamide—Asthenia—Acetazolamide—glaucoma	0.000554	0.0011	CcSEcCtD
Nilutamide—Dizziness—Bimatoprost—glaucoma	0.000553	0.0011	CcSEcCtD
Nilutamide—Nervousness—Betaxolol—glaucoma	0.000553	0.0011	CcSEcCtD
Nilutamide—Feeling abnormal—Pilocarpine—glaucoma	0.000551	0.00109	CcSEcCtD
Nilutamide—Discomfort—Clonidine—glaucoma	0.00055	0.00109	CcSEcCtD
Nilutamide—Vomiting—Apraclonidine—glaucoma	0.000548	0.00109	CcSEcCtD
Nilutamide—Gastrointestinal pain—Pilocarpine—glaucoma	0.000546	0.00109	CcSEcCtD
Nilutamide—Dry mouth—Clonidine—glaucoma	0.000544	0.00108	CcSEcCtD
Nilutamide—Dermatitis—Apraclonidine—glaucoma	0.000543	0.00108	CcSEcCtD
Nilutamide—Headache—Apraclonidine—glaucoma	0.00054	0.00107	CcSEcCtD
Nilutamide—Rhinitis—Timolol—glaucoma	0.000536	0.00106	CcSEcCtD
Nilutamide—Oedema—Clonidine—glaucoma	0.000534	0.00106	CcSEcCtD
Nilutamide—Asthenia—Brimonidine—glaucoma	0.000531	0.00106	CcSEcCtD
Nilutamide—Body temperature increased—Pilocarpine—glaucoma	0.000528	0.00105	CcSEcCtD
Nilutamide—Abdominal pain—Pilocarpine—glaucoma	0.000528	0.00105	CcSEcCtD
Nilutamide—Ill-defined disorder—Betaxolol—glaucoma	0.000528	0.00105	CcSEcCtD
Nilutamide—Diarrhoea—Acetazolamide—glaucoma	0.000528	0.00105	CcSEcCtD
Nilutamide—Rash—Bimatoprost—glaucoma	0.000527	0.00105	CcSEcCtD
Nilutamide—Dermatitis—Bimatoprost—glaucoma	0.000527	0.00105	CcSEcCtD
Nilutamide—Oedema peripheral—Timolol—glaucoma	0.000526	0.00105	CcSEcCtD
Nilutamide—Anaemia—Betaxolol—glaucoma	0.000526	0.00105	CcSEcCtD
Nilutamide—Shock—Clonidine—glaucoma	0.000525	0.00104	CcSEcCtD
Nilutamide—Pruritus—Brimonidine—glaucoma	0.000524	0.00104	CcSEcCtD
Nilutamide—Headache—Bimatoprost—glaucoma	0.000524	0.00104	CcSEcCtD
Nilutamide—Hyperhidrosis—Clonidine—glaucoma	0.000516	0.00103	CcSEcCtD
Nilutamide—Visual impairment—Timolol—glaucoma	0.000515	0.00102	CcSEcCtD
Nilutamide—Malaise—Betaxolol—glaucoma	0.000513	0.00102	CcSEcCtD
Nilutamide—Nausea—Apraclonidine—glaucoma	0.000512	0.00102	CcSEcCtD
Nilutamide—Syncope—Betaxolol—glaucoma	0.000511	0.00101	CcSEcCtD
Nilutamide—Dizziness—Acetazolamide—glaucoma	0.00051	0.00101	CcSEcCtD
Nilutamide—Anorexia—Clonidine—glaucoma	0.000509	0.00101	CcSEcCtD
Nilutamide—Asthenia—Dorzolamide—glaucoma	0.000507	0.00101	CcSEcCtD
Nilutamide—Asthenia—Travoprost—glaucoma	0.000505	0.001	CcSEcCtD
Nilutamide—Pruritus—Dorzolamide—glaucoma	0.0005	0.000995	CcSEcCtD
Nilutamide—Loss of consciousness—Betaxolol—glaucoma	0.0005	0.000995	CcSEcCtD
Nilutamide—Asthenia—Brinzolamide—glaucoma	0.000499	0.000992	CcSEcCtD
Nilutamide—Pruritus—Travoprost—glaucoma	0.000498	0.00099	CcSEcCtD
Nilutamide—Cough—Betaxolol—glaucoma	0.000497	0.000988	CcSEcCtD
Nilutamide—Nausea—Bimatoprost—glaucoma	0.000497	0.000988	CcSEcCtD
Nilutamide—Pruritus—Brinzolamide—glaucoma	0.000492	0.000978	CcSEcCtD
Nilutamide—Vomiting—Acetazolamide—glaucoma	0.000491	0.000975	CcSEcCtD
Nilutamide—Dizziness—Brimonidine—glaucoma	0.00049	0.000974	CcSEcCtD
Nilutamide—Chest pain—Betaxolol—glaucoma	0.000485	0.000964	CcSEcCtD
Nilutamide—Diarrhoea—Dorzolamide—glaucoma	0.000484	0.000962	CcSEcCtD
Nilutamide—Headache—Acetazolamide—glaucoma	0.000483	0.000961	CcSEcCtD
Nilutamide—Insomnia—Clonidine—glaucoma	0.000483	0.00096	CcSEcCtD
Nilutamide—Diarrhoea—Travoprost—glaucoma	0.000482	0.000958	CcSEcCtD
Nilutamide—Asthenia—Pilocarpine—glaucoma	0.000479	0.000953	CcSEcCtD
Nilutamide—Paraesthesia—Clonidine—glaucoma	0.000479	0.000953	CcSEcCtD
Nilutamide—Discomfort—Betaxolol—glaucoma	0.000479	0.000952	CcSEcCtD
Nilutamide—Dyspnoea—Clonidine—glaucoma	0.000476	0.000946	CcSEcCtD
Nilutamide—Diarrhoea—Brinzolamide—glaucoma	0.000476	0.000946	CcSEcCtD
Nilutamide—Dry mouth—Betaxolol—glaucoma	0.000474	0.000942	CcSEcCtD
Nilutamide—Pruritus—Pilocarpine—glaucoma	0.000473	0.00094	CcSEcCtD
Nilutamide—Alopecia—Timolol—glaucoma	0.000472	0.000939	CcSEcCtD
Nilutamide—Dizziness—Dorzolamide—glaucoma	0.000468	0.00093	CcSEcCtD
Nilutamide—Rash—Brimonidine—glaucoma	0.000467	0.000928	CcSEcCtD
Nilutamide—Dermatitis—Brimonidine—glaucoma	0.000467	0.000927	CcSEcCtD
Nilutamide—Dizziness—Travoprost—glaucoma	0.000466	0.000926	CcSEcCtD
Nilutamide—Oedema—Betaxolol—glaucoma	0.000465	0.000924	CcSEcCtD
Nilutamide—Headache—Brimonidine—glaucoma	0.000464	0.000922	CcSEcCtD
Nilutamide—Decreased appetite—Clonidine—glaucoma	0.000464	0.000922	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Clonidine—glaucoma	0.000461	0.000916	CcSEcCtD
Nilutamide—Dizziness—Brinzolamide—glaucoma	0.00046	0.000914	CcSEcCtD
Nilutamide—Nausea—Acetazolamide—glaucoma	0.000458	0.000911	CcSEcCtD
Nilutamide—Diarrhoea—Pilocarpine—glaucoma	0.000457	0.000909	CcSEcCtD
Nilutamide—Shock—Betaxolol—glaucoma	0.000457	0.000909	CcSEcCtD
Nilutamide—Tension—Timolol—glaucoma	0.000456	0.000907	CcSEcCtD
Nilutamide—Constipation—Clonidine—glaucoma	0.000456	0.000907	CcSEcCtD
Nilutamide—Pain—Clonidine—glaucoma	0.000456	0.000907	CcSEcCtD
Nilutamide—Nervousness—Timolol—glaucoma	0.000452	0.000898	CcSEcCtD
Nilutamide—Vomiting—Dorzolamide—glaucoma	0.00045	0.000894	CcSEcCtD
Nilutamide—Hyperhidrosis—Betaxolol—glaucoma	0.000449	0.000893	CcSEcCtD
Nilutamide—Rash—Dorzolamide—glaucoma	0.000446	0.000887	CcSEcCtD
Nilutamide—Dermatitis—Dorzolamide—glaucoma	0.000446	0.000886	CcSEcCtD
Nilutamide—Rash—Travoprost—glaucoma	0.000444	0.000883	CcSEcCtD
Nilutamide—Dermatitis—Travoprost—glaucoma	0.000444	0.000882	CcSEcCtD
Nilutamide—Headache—Dorzolamide—glaucoma	0.000443	0.000881	CcSEcCtD
Nilutamide—Anorexia—Betaxolol—glaucoma	0.000443	0.00088	CcSEcCtD
Nilutamide—Vomiting—Brinzolamide—glaucoma	0.000442	0.000879	CcSEcCtD
Nilutamide—Dizziness—Pilocarpine—glaucoma	0.000442	0.000879	CcSEcCtD
Nilutamide—Headache—Travoprost—glaucoma	0.000441	0.000877	CcSEcCtD
Nilutamide—Nausea—Brimonidine—glaucoma	0.00044	0.000874	CcSEcCtD
Nilutamide—Feeling abnormal—Clonidine—glaucoma	0.00044	0.000874	CcSEcCtD
Nilutamide—Rash—Brinzolamide—glaucoma	0.000438	0.000872	CcSEcCtD
Nilutamide—Dermatitis—Brinzolamide—glaucoma	0.000438	0.000871	CcSEcCtD
Nilutamide—Gastrointestinal pain—Clonidine—glaucoma	0.000436	0.000868	CcSEcCtD
Nilutamide—Headache—Brinzolamide—glaucoma	0.000436	0.000866	CcSEcCtD
Nilutamide—Vomiting—Pilocarpine—glaucoma	0.000425	0.000845	CcSEcCtD
Nilutamide—Abdominal pain—Clonidine—glaucoma	0.000422	0.000839	CcSEcCtD
Nilutamide—Body temperature increased—Clonidine—glaucoma	0.000422	0.000839	CcSEcCtD
Nilutamide—Rash—Pilocarpine—glaucoma	0.000421	0.000838	CcSEcCtD
Nilutamide—Dermatitis—Pilocarpine—glaucoma	0.000421	0.000837	CcSEcCtD
Nilutamide—Insomnia—Betaxolol—glaucoma	0.00042	0.000835	CcSEcCtD
Nilutamide—Nausea—Dorzolamide—glaucoma	0.00042	0.000835	CcSEcCtD
Nilutamide—Headache—Pilocarpine—glaucoma	0.000419	0.000832	CcSEcCtD
Nilutamide—Nausea—Travoprost—glaucoma	0.000418	0.000832	CcSEcCtD
Nilutamide—Paraesthesia—Betaxolol—glaucoma	0.000417	0.000829	CcSEcCtD
Nilutamide—Syncope—Timolol—glaucoma	0.000417	0.000829	CcSEcCtD
Nilutamide—Dyspnoea—Betaxolol—glaucoma	0.000414	0.000824	CcSEcCtD
Nilutamide—Nausea—Brinzolamide—glaucoma	0.000413	0.000821	CcSEcCtD
Nilutamide—Dyspepsia—Betaxolol—glaucoma	0.000409	0.000813	CcSEcCtD
Nilutamide—Loss of consciousness—Timolol—glaucoma	0.000409	0.000813	CcSEcCtD
Nilutamide—Cough—Timolol—glaucoma	0.000406	0.000807	CcSEcCtD
Nilutamide—Decreased appetite—Betaxolol—glaucoma	0.000404	0.000803	CcSEcCtD
Nilutamide—POR—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000403	0.0766	CbGpPWpGaD
Nilutamide—Hypertension—Timolol—glaucoma	0.000402	0.000798	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Betaxolol—glaucoma	0.000401	0.000797	CcSEcCtD
Nilutamide—Constipation—Betaxolol—glaucoma	0.000397	0.00079	CcSEcCtD
Nilutamide—Pain—Betaxolol—glaucoma	0.000397	0.00079	CcSEcCtD
Nilutamide—Nausea—Pilocarpine—glaucoma	0.000397	0.000789	CcSEcCtD
Nilutamide—Chest pain—Timolol—glaucoma	0.000396	0.000787	CcSEcCtD
Nilutamide—Discomfort—Timolol—glaucoma	0.000391	0.000778	CcSEcCtD
Nilutamide—Dry mouth—Timolol—glaucoma	0.000387	0.00077	CcSEcCtD
Nilutamide—Asthenia—Clonidine—glaucoma	0.000383	0.000761	CcSEcCtD
Nilutamide—Feeling abnormal—Betaxolol—glaucoma	0.000383	0.000761	CcSEcCtD
Nilutamide—Oedema—Timolol—glaucoma	0.00038	0.000755	CcSEcCtD
Nilutamide—Pruritus—Clonidine—glaucoma	0.000378	0.000751	CcSEcCtD
Nilutamide—Shock—Timolol—glaucoma	0.000373	0.000742	CcSEcCtD
Nilutamide—Body temperature increased—Betaxolol—glaucoma	0.000367	0.00073	CcSEcCtD
Nilutamide—Hyperhidrosis—Timolol—glaucoma	0.000367	0.000729	CcSEcCtD
Nilutamide—Diarrhoea—Clonidine—glaucoma	0.000365	0.000726	CcSEcCtD
Nilutamide—Anorexia—Timolol—glaucoma	0.000362	0.000719	CcSEcCtD
Nilutamide—Dizziness—Clonidine—glaucoma	0.000353	0.000702	CcSEcCtD
Nilutamide—Insomnia—Timolol—glaucoma	0.000343	0.000682	CcSEcCtD
Nilutamide—Paraesthesia—Timolol—glaucoma	0.000341	0.000678	CcSEcCtD
Nilutamide—Vomiting—Clonidine—glaucoma	0.000339	0.000675	CcSEcCtD
Nilutamide—Dyspnoea—Timolol—glaucoma	0.000338	0.000673	CcSEcCtD
Nilutamide—Rash—Clonidine—glaucoma	0.000336	0.000669	CcSEcCtD
Nilutamide—Dermatitis—Clonidine—glaucoma	0.000336	0.000668	CcSEcCtD
Nilutamide—Headache—Clonidine—glaucoma	0.000334	0.000665	CcSEcCtD
Nilutamide—Dyspepsia—Timolol—glaucoma	0.000334	0.000664	CcSEcCtD
Nilutamide—Asthenia—Betaxolol—glaucoma	0.000333	0.000663	CcSEcCtD
Nilutamide—Decreased appetite—Timolol—glaucoma	0.00033	0.000656	CcSEcCtD
Nilutamide—Pruritus—Betaxolol—glaucoma	0.000329	0.000654	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Timolol—glaucoma	0.000328	0.000651	CcSEcCtD
Nilutamide—Pain—Timolol—glaucoma	0.000325	0.000645	CcSEcCtD
Nilutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—PITX2—glaucoma	0.000319	0.0606	CbGpPWpGaD
Nilutamide—Diarrhoea—Betaxolol—glaucoma	0.000318	0.000632	CcSEcCtD
Nilutamide—Nausea—Clonidine—glaucoma	0.000317	0.00063	CcSEcCtD
Nilutamide—Feeling abnormal—Timolol—glaucoma	0.000313	0.000622	CcSEcCtD
Nilutamide—Gastrointestinal pain—Timolol—glaucoma	0.00031	0.000617	CcSEcCtD
Nilutamide—Dizziness—Betaxolol—glaucoma	0.000307	0.000611	CcSEcCtD
Nilutamide—Abdominal pain—Timolol—glaucoma	0.0003	0.000597	CcSEcCtD
Nilutamide—Body temperature increased—Timolol—glaucoma	0.0003	0.000597	CcSEcCtD
Nilutamide—Vomiting—Betaxolol—glaucoma	0.000295	0.000587	CcSEcCtD
Nilutamide—Rash—Betaxolol—glaucoma	0.000293	0.000582	CcSEcCtD
Nilutamide—Dermatitis—Betaxolol—glaucoma	0.000293	0.000582	CcSEcCtD
Nilutamide—Headache—Betaxolol—glaucoma	0.000291	0.000579	CcSEcCtD
Nilutamide—Nausea—Betaxolol—glaucoma	0.000276	0.000549	CcSEcCtD
Nilutamide—Asthenia—Timolol—glaucoma	0.000272	0.000541	CcSEcCtD
Nilutamide—Pruritus—Timolol—glaucoma	0.000269	0.000534	CcSEcCtD
Nilutamide—Diarrhoea—Timolol—glaucoma	0.00026	0.000516	CcSEcCtD
Nilutamide—Dizziness—Timolol—glaucoma	0.000251	0.000499	CcSEcCtD
Nilutamide—Vomiting—Timolol—glaucoma	0.000241	0.00048	CcSEcCtD
Nilutamide—Rash—Timolol—glaucoma	0.000239	0.000476	CcSEcCtD
Nilutamide—Dermatitis—Timolol—glaucoma	0.000239	0.000475	CcSEcCtD
Nilutamide—Headache—Timolol—glaucoma	0.000238	0.000473	CcSEcCtD
Nilutamide—Nausea—Timolol—glaucoma	0.000225	0.000448	CcSEcCtD
Nilutamide—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.000215	0.0409	CbGpPWpGaD
Nilutamide—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.000196	0.0372	CbGpPWpGaD
Nilutamide—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.000192	0.0365	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—LMX1B—glaucoma	0.000187	0.0355	CbGpPWpGaD
Nilutamide—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.000175	0.0333	CbGpPWpGaD
Nilutamide—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.000175	0.0332	CbGpPWpGaD
Nilutamide—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.00016	0.0303	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.000159	0.0302	CbGpPWpGaD
Nilutamide—AR—FOXA1 transcription factor network—SOD1—glaucoma	0.000105	0.0199	CbGpPWpGaD
Nilutamide—CYP2C8—Tamoxifen metabolism—CYP1B1—glaucoma	9.96e-05	0.0189	CbGpPWpGaD
Nilutamide—AR—Nuclear Receptors—NR3C1—glaucoma	9.79e-05	0.0186	CbGpPWpGaD
Nilutamide—CYP2C19—Tamoxifen metabolism—CYP1B1—glaucoma	8.89e-05	0.0169	CbGpPWpGaD
Nilutamide—CYP2C9—Tamoxifen metabolism—CYP1B1—glaucoma	8.1e-05	0.0154	CbGpPWpGaD
Nilutamide—AR—Nuclear Receptor transcription pathway—NR3C1—glaucoma	7.74e-05	0.0147	CbGpPWpGaD
Nilutamide—AR—Regulation of Androgen receptor activity—NR3C1—glaucoma	7.51e-05	0.0143	CbGpPWpGaD
Nilutamide—CYP2C19—Melatonin metabolism and effects—CYP1B1—glaucoma	6.86e-05	0.013	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND2—glaucoma	6.86e-05	0.013	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—HDAC9—glaucoma	6.71e-05	0.0127	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear SMAD2/3 signaling—CDKN2B—glaucoma	6.09e-05	0.0116	CbGpPWpGaD
Nilutamide—CYP2C19—Melatonin metabolism and effects—EDN1—glaucoma	5.55e-05	0.0105	CbGpPWpGaD
Nilutamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	5.51e-05	0.0105	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear SMAD2/3 signaling—NR3C1—glaucoma	5.35e-05	0.0102	CbGpPWpGaD
Nilutamide—AR—FOXA1 transcription factor network—CDKN1B—glaucoma	5.03e-05	0.00955	CbGpPWpGaD
Nilutamide—CYP2C8—Arachidonic acid metabolism—CYP1B1—glaucoma	4.97e-05	0.00945	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—NTRK2—glaucoma	4.8e-05	0.00912	CbGpPWpGaD
Nilutamide—AR—Notch-mediated HES/HEY network—CDKN1B—glaucoma	4.77e-05	0.00906	CbGpPWpGaD
Nilutamide—CYP2C19—Melatonin metabolism and effects—APOE—glaucoma	4.51e-05	0.00857	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	4.46e-05	0.00848	CbGpPWpGaD
Nilutamide—CYP2C19—Arachidonic acid metabolism—CYP1B1—glaucoma	4.44e-05	0.00843	CbGpPWpGaD
Nilutamide—AR—Coregulation of Androgen receptor activity—CDKN2A—glaucoma	4.37e-05	0.0083	CbGpPWpGaD
Nilutamide—AR—Androgen receptor signaling pathway—CAV1—glaucoma	4.37e-05	0.0083	CbGpPWpGaD
Nilutamide—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	4.3e-05	0.00816	CbGpPWpGaD
Nilutamide—CYP2C8—Oxidation by Cytochrome P450—CYP1B1—glaucoma	4.24e-05	0.00806	CbGpPWpGaD
Nilutamide—CYP2C9—Arachidonic acid metabolism—CYP1B1—glaucoma	4.05e-05	0.00769	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—glaucoma	3.84e-05	0.00729	CbGpPWpGaD
Nilutamide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	3.84e-05	0.00729	CbGpPWpGaD
Nilutamide—CYP2C19—Oxidation by Cytochrome P450—CYP1B1—glaucoma	3.79e-05	0.00719	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—BDNF—glaucoma	3.58e-05	0.0068	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—glaucoma	3.52e-05	0.00668	CbGpPWpGaD
Nilutamide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	3.5e-05	0.00664	CbGpPWpGaD
Nilutamide—CYP2C8—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	3.48e-05	0.00662	CbGpPWpGaD
Nilutamide—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—glaucoma	3.45e-05	0.00656	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—IL1A—glaucoma	3.44e-05	0.00653	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	3.33e-05	0.00632	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—NGF—glaucoma	3.18e-05	0.00604	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—NR3C1—glaucoma	3.16e-05	0.00601	CbGpPWpGaD
Nilutamide—CYP2C19—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	3.11e-05	0.00591	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	3.07e-05	0.00582	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	3.05e-05	0.00579	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—MMP1—glaucoma	2.98e-05	0.00567	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—glaucoma	2.89e-05	0.00548	CbGpPWpGaD
Nilutamide—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	2.84e-05	0.00539	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—BAD—glaucoma	2.69e-05	0.00511	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	2.61e-05	0.00495	CbGpPWpGaD
Nilutamide—CYP2C8—Biological oxidations—GSTT1—glaucoma	2.32e-05	0.00441	CbGpPWpGaD
Nilutamide—CYP2C8—Arachidonic acid metabolism—PTGS2—glaucoma	2.24e-05	0.00426	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	2.23e-05	0.00424	CbGpPWpGaD
Nilutamide—CYP2C19—Biological oxidations—GSTT1—glaucoma	2.07e-05	0.00394	CbGpPWpGaD
Nilutamide—CYP2C19—Arachidonic acid metabolism—PTGS2—glaucoma	2e-05	0.0038	CbGpPWpGaD
Nilutamide—CYP2C9—Biological oxidations—GSTT1—glaucoma	1.89e-05	0.00359	CbGpPWpGaD
Nilutamide—CYP2C8—Biological oxidations—CYP1B1—glaucoma	1.85e-05	0.00352	CbGpPWpGaD
Nilutamide—CYP2C8—Metapathway biotransformation—CYP1B1—glaucoma	1.83e-05	0.00347	CbGpPWpGaD
Nilutamide—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	1.82e-05	0.00346	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—CTSA—glaucoma	1.73e-05	0.00328	CbGpPWpGaD
Nilutamide—CYP2C19—Biological oxidations—CYP1B1—glaucoma	1.65e-05	0.00314	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	1.64e-05	0.00311	CbGpPWpGaD
Nilutamide—CYP2C19—Metapathway biotransformation—CYP1B1—glaucoma	1.63e-05	0.00309	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—NARFL—glaucoma	1.63e-05	0.00309	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CA5A—glaucoma	1.63e-05	0.00309	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—VEGFA—glaucoma	1.56e-05	0.00296	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	1.55e-05	0.00295	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—CTSA—glaucoma	1.54e-05	0.00293	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—CDKN2B—glaucoma	1.52e-05	0.00289	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—VEGFA—glaucoma	1.52e-05	0.00288	CbGpPWpGaD
Nilutamide—CYP2C9—Biological oxidations—CYP1B1—glaucoma	1.51e-05	0.00286	CbGpPWpGaD
Nilutamide—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	1.49e-05	0.00282	CbGpPWpGaD
Nilutamide—CYP2C8—Biological oxidations—GSTM1—glaucoma	1.48e-05	0.00281	CbGpPWpGaD
Nilutamide—CYP2C8—Metapathway biotransformation—GSTM1—glaucoma	1.46e-05	0.00277	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CA5A—glaucoma	1.45e-05	0.00276	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—NARFL—glaucoma	1.45e-05	0.00276	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	1.41e-05	0.00267	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—NR3C1—glaucoma	1.34e-05	0.00254	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CA5A—glaucoma	1.33e-05	0.00252	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—NARFL—glaucoma	1.33e-05	0.00252	CbGpPWpGaD
Nilutamide—CYP2C19—Biological oxidations—GSTM1—glaucoma	1.32e-05	0.00251	CbGpPWpGaD
Nilutamide—CYP2C19—Metapathway biotransformation—GSTM1—glaucoma	1.3e-05	0.00247	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—TNF—glaucoma	1.3e-05	0.00247	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	1.29e-05	0.00245	CbGpPWpGaD
Nilutamide—CYP2C9—Biological oxidations—GSTM1—glaucoma	1.2e-05	0.00229	CbGpPWpGaD
Nilutamide—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	1.19e-05	0.00226	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—TP53—glaucoma	1.18e-05	0.00224	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	1.11e-05	0.0021	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	9.76e-06	0.00185	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CA1—glaucoma	7.95e-06	0.00151	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CTSA—glaucoma	7.7e-06	0.00146	CbGpPWpGaD
Nilutamide—AR—Gene Expression—CDKN2B—glaucoma	7.33e-06	0.00139	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CA2—glaucoma	7.27e-06	0.00138	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	7.11e-06	0.00135	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	7.11e-06	0.00135	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CA1—glaucoma	7.1e-06	0.00135	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CTSA—glaucoma	6.87e-06	0.00131	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CA2—glaucoma	6.49e-06	0.00123	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CA1—glaucoma	6.47e-06	0.00123	CbGpPWpGaD
Nilutamide—AR—Gene Expression—NR3C1—glaucoma	6.44e-06	0.00122	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	6.34e-06	0.0012	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	6.34e-06	0.0012	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CTSA—glaucoma	6.27e-06	0.00119	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CA2—glaucoma	5.92e-06	0.00112	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	5.79e-06	0.0011	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	5.79e-06	0.0011	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—TXN—glaucoma	5.12e-06	0.000973	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—APOE—glaucoma	4.68e-06	0.000888	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—glaucoma	4.63e-06	0.00088	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—TXN—glaucoma	4.57e-06	0.000869	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—glaucoma	4.17e-06	0.000793	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—TXN—glaucoma	4.17e-06	0.000792	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—glaucoma	4.13e-06	0.000785	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GSTT1—glaucoma	3.97e-06	0.000755	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	3.81e-06	0.000723	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	3.77e-06	0.000716	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GSTT1—glaucoma	3.55e-06	0.000673	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GSTT1—glaucoma	3.23e-06	0.000614	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	3.2e-06	0.000608	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ABCA1—glaucoma	3.17e-06	0.000601	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CYP1B1—glaucoma	3.17e-06	0.000601	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.86e-06	0.000543	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CYP1B1—glaucoma	2.83e-06	0.000537	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ABCA1—glaucoma	2.83e-06	0.000537	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.61e-06	0.000495	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CYP1B1—glaucoma	2.58e-06	0.000489	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ABCA1—glaucoma	2.58e-06	0.000489	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GSTM1—glaucoma	2.53e-06	0.000481	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GSTM1—glaucoma	2.26e-06	0.000429	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—MTHFR—glaucoma	2.24e-06	0.000425	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—APOE—glaucoma	2.08e-06	0.000395	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CAV1—glaucoma	2.06e-06	0.000392	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GSTM1—glaucoma	2.06e-06	0.000391	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—MTHFR—glaucoma	2e-06	0.000379	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—APOE—glaucoma	1.86e-06	0.000353	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CAV1—glaucoma	1.84e-06	0.00035	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—MTHFR—glaucoma	1.82e-06	0.000346	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—APOE—glaucoma	1.69e-06	0.000322	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CAV1—glaucoma	1.68e-06	0.000319	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—NOS3—glaucoma	1.56e-06	0.000296	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PTGS2—glaucoma	1.43e-06	0.000271	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—NOS3—glaucoma	1.39e-06	0.000264	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PTGS2—glaucoma	1.27e-06	0.000242	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—NOS3—glaucoma	1.27e-06	0.000241	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PTGS2—glaucoma	1.16e-06	0.000221	CbGpPWpGaD
